PomDoctor Limited (POM), based in Guangzhou, China, priced its small IPO at $4.00 – the low end of its $4.00-to-$6.00 range – and sold 5 million shares to raise $20 million on Tuesday night, Oct. 7, 2025. PomDoctor’s stock is expected to start trading today – Wednesday, Oct. 8, 2025 – on the NASDAQ.
Joseph Stone Capital was the sole book-runner.
PomDoctor is a telehealth company focused on serving people living with diabetes, high blood pressure and other chronic diseases.
“We are a leading online medical services platform for chronic diseases in China,” PomDoctor said in the prospectus.
As of Dec. 31, 2024, PomDoctor had over 212,800 doctors (under contract) who had issued about 3.13 million prescriptions. The company had 699,000 patients (also referred to as transacting patients) as of Dec. 31, 2024.
“Our mission is to provide effective prevention and treatment solutions to alleviate patients’ suffering from illnesses,” PomDoctor said in the prospectus.
The company is not profitable: PomDoctor reported a net loss of $5.12 million on revenue of $46.93 million (in U.S. dollars converted from China’s currency) for the 12 months that ended Dec. 31, 2024.
(For more information about these companies, please check the IPO Calendar and the individual IPO Profiles found on the IPOScoop.com website.)
Note: Never trade on proposed symbols. They have been known to change and you might buy something on the OTC Bulletin Board.
To see what time the NASDAQ IPOs are expected to trade, please log in to: NASDAQTrader.com then scroll down to IPO Message.
Disclosure: Nobody on the IPOScoop.com staff has a position in any stocks mentioned above, nor do they trade or invest in IPOs. The IPOScoop.com staff does not issue advice, recommendations or opinions.